[Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes]

Nouv Rev Fr Hematol (1978). 1994 Aug;36(4):289-91.
[Article in French]
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Anti-Bacterial Agents
  • Antifungal Agents / therapeutic use
  • Bacterial Infections / drug therapy*
  • Bacterial Infections / etiology
  • Contraindications
  • Drug Resistance, Microbial
  • Drug Therapy, Combination / administration & dosage
  • Drug Therapy, Combination / therapeutic use*
  • Fever / etiology*
  • France
  • Humans
  • Immunocompromised Host
  • Leukocyte Count
  • Mycoses / drug therapy
  • Neutropenia / blood
  • Neutropenia / complications*
  • Recurrence
  • Teicoplanin / therapeutic use
  • Time Factors
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Teicoplanin
  • Vancomycin